Sources | Names Used |
---|---|
CCLE, FIMM | Vandetanib |
CTRPv2 | vandetanib |
PharmacoGx | Vandetanib |
Database | Identifier |
---|---|
Smiles: | CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC |
Inchikey: | UHTHHESEBZOYNR-UHFFFAOYSA-N |
Pubchem: | 3081361 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TMEM145 | CTRPv2 | pan-cancer | AAC | -0.15 | 9e-05 |
mRNA | ZNF165 | CCLE | pan-cancer | AAC | 0.22 | 9e-05 |
mRNA | BTC | CCLE | pan-cancer | AAC | 0.2 | 0.0001 |
mRNA | SLFN13 | CCLE | pan-cancer | AAC | 0.19 | 0.0001 |
mRNA | RAB25 | CCLE | pan-cancer | AAC | 0.23 | 0.0001 |
mRNA | SV2A | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
mRNA | TACSTD2 | CCLE | pan-cancer | AAC | 0.23 | 0.0001 |
mRNA | CTSV | CCLE | pan-cancer | AAC | 0.22 | 0.0001 |
mRNA | BTBD7 | CCLE | pan-cancer | AAC | 0.19 | 0.0001 |
mRNA | IRF6 | CCLE | pan-cancer | AAC | 0.23 | 0.0001 |